Share Your Research, Maximize Your Social Impacts
Main Menu
Searching By
PARTNERS
2020 - The Impact of COVID-19 on Early Clinical Development – What the New Landscape Will Look Like
Date2020-07-13
Deadline2020-07-13
VenueOnline, Canada 
KeywordsTumor First in Human; Regulatory Affairs; COVID-19
Websitehttps://xtalks.com
Topics/Call fo Papers
Virology, immunology and epidemiology of COVID-19
Virus detection tests and anti-SARS-CoV-2 antibody tests; reality check on reliability and availability
COVID-19 infection risk in early clinical drug development; risk minimalization by trial design & execution
The legacy of COVID-19: impact on FDA, EMA and MHRA regulatory guidances & the regulatory landscape after the pandemic
Virus detection tests and anti-SARS-CoV-2 antibody tests; reality check on reliability and availability
COVID-19 infection risk in early clinical drug development; risk minimalization by trial design & execution
The legacy of COVID-19: impact on FDA, EMA and MHRA regulatory guidances & the regulatory landscape after the pandemic
Other CFPs
- Biomarkers in Immuno-Oncology: Identifying and Implementing Biomarker Testing from Exploratory Research to Clinical Trials
- Pack Of 10 - Top Rated Finance Course Bundle
- Build Organizational Resilience Amid COVID-19 Crisis: Insights and Techniques for Leaders
- 2020 5th International Conference on Mechanical, Control and Computer Engineering (ICMCCE 2020)
- COVID-19 in the Workplace: How to Plan, Prevent, and Prepare for a Pandemic
Last modified: 2020-07-08 23:05:49